Carfilzomib: Irreversible Peptide Epoxyketone for Targeted Cancer Therapy

Carfilzomib is an irreversible peptide epoxyketone that functions as a potent proteasome inhibitor, widely used in cancer therapy, particularly for multiple myeloma treatment. As a product designed for research and pharmaceutical applications, Carfilzomib offers high specificity and efficacy in targeting proteasomal activity, thereby promoting apoptosis in malignant cells. Xinchem Corporation, a leading manufacturer and supplier based in China, specializes in the production of high-quality Carfilzomib with rigorous quality control and competitive pricing. With state-of-the-art factory facilities, Xinchem Corporation ensures reliable supply and consistent product performance to meet the demands of global pharmaceutical and research industries. As a trusted China-based manufacturer and supplier, Xinchem Corporation is committed to advancing healthcare innovations through premium biochemical products like Carfilzomib.

Related Products